ClinConnect ClinConnect Logo
Search / Trial NCT03427996

Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice

Launched by SEUNG-JUNG PARK · Feb 5, 2018

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Rotational Atherectomy

ClinConnect Summary

This clinical trial is studying a procedure called rotational atherectomy, which is used to treat a condition known as coronary stenosis. This condition occurs when the arteries that supply blood to the heart become narrowed due to a buildup of plaque. The goal of the trial is to evaluate how effective and safe this procedure is when used in everyday clinical practice.

To participate in the trial, individuals must be at least 19 years old and have already received the rotational atherectomy treatment. They also need to agree to follow the study’s guidelines and provide written consent. Unfortunately, people with a life expectancy of less than one year are not eligible to join. Participants can expect to have regular check-ups and follow-ups as part of the study to monitor their health and the outcomes of the procedure. Overall, this research aims to improve understanding of how well rotational atherectomy works for patients with narrowed coronary arteries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients ≥ 19 years old
  • Patients who received rotational atherectomy
  • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
  • Exclusion Criteria:
  • Life expectancy \<1y

About Seung Jung Park

Seung-Jung Park is a distinguished clinical trial sponsor recognized for his commitment to advancing medical research and innovation. With a focus on cardiology and interventional procedures, he leads initiatives that aim to improve patient outcomes through rigorous clinical trials. His expertise in trial design and execution ensures adherence to the highest ethical standards and regulatory requirements. By fostering collaboration among multidisciplinary teams, Seung-Jung Park drives the development of cutting-edge therapies, contributing significantly to the scientific community and enhancing the landscape of modern medicine.

Locations

Daegu, , Korea, Republic Of

Daejeon, , Korea, Republic Of

Seoul, , Korea, Republic Of

Pusan, , Korea, Republic Of

Gwangju, , Korea, Republic Of

Gwangju, , Korea, Republic Of

Bucheon, , Korea, Republic Of

Seongnam, , Korea, Republic Of

Daejeon, , Korea, Republic Of

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials